Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinases Block Internalization of δ-Opioid Receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 2, 2004, Pages 776-785

  Eisinger, Daniela A ^a   Schulz, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DELTA OPIATE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ETORPHINE; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MORPHINE; OPIATE AGONIST; PACLITAXEL; PROTEIN KINASE C; RETINA S ANTIGEN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; DRUG EXPOSURE; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ARRESTINS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DRUG INTERACTIONS; ENDOCYTOSIS; ENZYME ACTIVATION; ETORPHINE; FLAVONOIDS; GLUTAMIC ACID; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; NAPHTHALENES; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTORS, OPIOID, DELTA; TYRPHOSTINS;

EID: 2142715924     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.061788     Document Type: Article

References (46)

1. Ai W, Gong J, and Yu L (1999) MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway. FEBS Lett 456:196-200.
2. Ammer H and Schulz R (1997) Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction inpalmitoylated Gs alpha. Mol Pharmacol 52:993-999.
3. Ammer H and Schulz R (2000) Opioid tolerance/dependence in neuroblastoma x glioma (NG108-15) hybrid cells is associated with a reduction in spontaneous stimulatory receptor activity. FEBS Lett 485:157-162.
4. Belcheva MM, Szucs M, Wang D, Sadee W, and Coscia CJ (2001) mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:33847-33853.
5. Budd DC, Rae A, and Tobin AB (1999) Activation of the mitogen-activated protein kinase pathway by a Gq/11-coupled muscarinic receptor is independent of receptor internalization. J Biol Chem 274:12355-12360.
6. Bünemann M and Hosey MM (1999) G-protein coupled receptor kinases as modulators of G-protein signalling. J Physiol (Lond) 517:5-23.
7. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO(Eur Mol Biol Organ) J 16:7032-7044.
8. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, and Bunnett NW (2000) beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
9. Earnest S, Khokhlatchev A, Albanesi JP, and Barylko B (1996) Phosphorylation of dynamin by ERK2 inhibits the dynamin-microtubule interaction. FEBS Lett 396:62-66.
10. Eisinger DA, Ammer H, and Schulz R (2002) Chronic morphine treatment inhibits opioid receptor desensitization and internalization. J Neurosci 22:10192-10200.
11. Ferguson SS and Caron MG (1998) G protein-coupled receptor adaptation mechanisms. Semin Cell Dev Biol 9:119-127.
12. Ferguson SS, Downey WE 3rd, Colapietro AM, Barak LS, Menard L, and Caron MG (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (Wash DC) 271:363-366.
13. Gaidarov I and Keen JH (1999) Phosphoinositide-AP-2 interactions required for targeting to plasma membrane clathrin-coated pits. J Cell Biol 146:755-764.
14. Gaidarov I, Krupnick JG, Falck JR, Benovic JL, and Keen JH (1999) Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO (Eur Mol Biol Organ) J 18:871-881.
15. Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, and Benovic JL (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature (Lond) 383:447-450.
16. Henis YI and Elson EL (1981) Inhibition of the mobility of mouse lymphocyte surface immunoglobulins by locally bound concanavalin A. Proc Natl Acad Sci USA 78:1072-1076.
17. Heuser JE and Anderson RG (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108:389-400.
18. Johnson GL and Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK and p38 protein kinases. Science (Wash DC) 298:1911-1912.
19. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
20. Kramer HK, Andria ML, Esposito DH, and Simon EJ (2000) Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization. Biochem Pharmacol 60:781-792.
21. Lin FT, Miller WE, Luttrell LM, and Lefkowitz RJ (1999) Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem 274:15971-15974.
22. Liu QR, Zhang PW, Zhen Q, Walther D, Wang XB, and Uhl GR (2002) KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine. J Biol Chem 277:13312-13320.
23. Mundell SJ and Kelly E (1998) The effect of inhibitors of receptor internalization on the desensitization and resensitization of three Gs-coupled receptor responses. Br J Pharmacol 125:1594-1600.
24. Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, and Rockman HA (2002) Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 158:563-575.
25. Narita M, Funada M, and Suzuki T (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89:1-15.
26. Okano J and Rustgi AK (2001) Paclitaxel induces prolonged activation of the Ras/ MEK/ERK pathway independently of activating the programmed cell death machinery. J Biol Chem 276:19555-19564.
27. Pierce KL, Luttrell LM, and Lefkowitz RJ (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532-1539.
28. Pitcher JA, Tesmer JJ, Freeman JL, Capel WD, Stone WC, and Lefkowitz RJ (1999) Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem 274:34531-34534.
29. Rao S, He L, Chakravarty S, Ojima I, Orr GA, and Horwitz SB (1999) Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol. J Biol Chem 274:37990-37994.
30. Sano M and Kitajima S (1998) Activation of mitogen-activated protein kinases is not required for the extension of neurites from PC12D cells triggered by nerve growth factor. Brain Res 785:299-308.
31. Schiff PB, Fant J, and Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature (Lond) 277:665-667.
32. Schmidt H, Schulz S, Klutzny M, Koch T, Handel M, and Hollt V (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J Neurochem 74:414-422.
33. Schulz R, Wehmeyer A, and Schulz K (2002) Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J Pharmacol Exp Ther 300:376-384.
34. Shah BH, Alberto Olivares-Reyes J, Yesilkaya A, and Catt KJ (2002) Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes. Mol Endocrinol 16:610-620.
35. Sood PP and Mohanakumar KP (1985) Inhibition of acid and alkaline phosphatases in the central nervous system of mice during morphine dependence development, withdrawal and naloxone administration. Cell Mol Biol 31:469-473.
36. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW, et al. (2000) Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275:12200-12206.
37. Sternini C, Spann M, Anton B, Keith DE Jr, Bunnett NW, von Zastrow M, Evans C, and Brecha NC (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93:9241-9246.
38. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, and Luttrell LM (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277:9429-9436.
39. Trapaidze N, Keith DE, Cvejic S, Evans CJ, and Devi LA (1996) Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. J Biol Chem 271:29279-29285.
40. Ueda H, Inoue M, and Matsumoto T (2001) Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia. J Neurosci 21:2967-2973.
41. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci USA 95:9914-9919.
42. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
43. Yarden Y and Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.
44. Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, and Bell GI (1993) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci USA 90:6736-6740.
45. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.
46. Zhang J, Ferguson SS, Law PY, Barak LS, and Caron MG (1999) Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin. J Recept Signal Transduct Res 19:301-313.